cyclohexanol has been researched along with Heart Defects, Congenital in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artama, M; Engeland, A; Furu, K; Gissler, M; Haglund, B; Kieler, H; Malm, H; Nørgaard, M; Selmer, R; Stephansson, O; Valdimarsdottir, UA; Zoega, H | 1 |
Dolman, C; Howard, LM; Khalifeh, H | 1 |
2 other study(ies) available for cyclohexanol and Heart Defects, Congenital
Article | Year |
---|---|
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Topics: Adult; Cohort Studies; Contraindications; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Logistic Models; Odds Ratio; Population Surveillance; Pregnancy; Pregnancy Complications; Scandinavian and Nordic Countries; Selective Serotonin Reuptake Inhibitors; Siblings; Venlafaxine Hydrochloride | 2015 |
Safety of psychotropic drugs in pregnancy.
Topics: Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors | 2015 |